The Complete Guide to Startup Valuation Methods

Valuation is the single most contentious number in any fundraise. Founders want it high. Investors want it reasonable. And both sides are working with imperfect information about a company that may not have meaningful revenue yet. Unlike public companies, where the market sets a price every second, startup valuation is part science, part art, and part negotiation leverage.

Understanding valuation methods isn't just academic. It directly affects how much of your company you give away, what governance terms you accept, and how your cap table looks when you raise your next round. Founders who understand valuation negotiate better, set more realistic expectations, and avoid the trap of over-optimizing for a high number at the expense of good terms.

This guide covers every major valuation methodology used in venture capital, from early-stage heuristics to sophisticated financial models. By the end, you'll understand not just how valuations are calculated, but why different methods produce different numbers and which ones matter most at each stage.

Why Startup Valuation Is Different From Public Company Valuation

Public company valuation is relatively straightforward. You take the share price, multiply by outstanding shares, and you have a market capitalization. Analysts can run discounted cash flow models using years of historical data, compare ratios against industry peers, and arrive at a defensible price target. The inputs are real, audited, and abundant.

Startup valuation operates in an entirely different universe. Early-stage companies often have no revenue, no profits, and sometimes no product. The historical data is measured in months, not years. The comparable companies might not exist yet. And the future is genuinely uncertain in ways that established companies never face — will this product work? Will customers pay? Will the market develop as expected?

This uncertainty is why startup valuation relies on a blend of quantitative methods and qualitative judgment. The numbers provide a framework, but the final valuation is shaped by factors like team quality, market timing, competitive dynamics, and the leverage each side brings to the negotiation. Two companies with identical metrics can command very different valuations based on these qualitative factors.

The Venture Capital Method

The VC method, first articulated by Professor William Sahlman at Harvard Business School, is the most commonly used approach for early-stage startup valuation. It works backward from a projected exit value to determine what the company should be worth today, given the investor's required return.

Here's how it works step by step. First, estimate the company's value at exit — typically 5 to 7 years in the future. This might be based on projected revenue multiplied by an industry-appropriate multiple. For example, if you project $50 million in revenue at exit and similar companies trade at 10x revenue, the exit value would be $500 million.

Second, determine the investor's required return. Early-stage VCs typically target 10x to 30x returns on individual investments, reflecting the high failure rate in their portfolios. A seed investor might require a 20x return; a Series A investor might target 10x.

Third, divide the exit value by the required return to get the post-money valuation today. Using our example: $500 million exit divided by 20x required return equals a $25 million post-money valuation. If the investor puts in $5 million, the pre-money valuation is $20 million, and they own 20% of the company.

The VC method is elegant in its simplicity, but it has significant limitations. The exit value projection is speculative. The required return is somewhat arbitrary. And the method doesn't account for dilution from future funding rounds, which can dramatically reduce an early investor's ownership percentage. Sophisticated investors adjust for expected dilution, which lowers the acceptable pre-money valuation further.

Comparable Company Analysis (Comps)

Comparable company analysis — or "comps" — values a startup by looking at what similar companies have been valued at in recent funding rounds or acquisitions. The logic is straightforward: if three companies similar to yours recently raised at 15x to 20x annual recurring revenue, that's a reasonable benchmark for your valuation.

The key to good comps analysis is selecting truly comparable companies. This means matching on several dimensions: stage (seed, Series A, etc.), sector (SaaS, fintech, healthcare), business model (subscription, marketplace, transactional), growth rate, geographic focus, and market size. A pre-revenue AI startup is not comparable to a profitable e-commerce company, even if both just raised a Series A.

Common valuation multiples used in comps analysis include:

• Revenue multiples (EV/Revenue): The most common for growth-stage startups. SaaS companies in 2026 typically trade at 8x to 25x ARR depending on growth rate, retention, and margin profile. A company growing 100%+ year-over-year will command a significantly higher multiple than one growing 30%.
• ARR multiples: Specific to SaaS, this looks at annual recurring revenue as the base. It's the preferred metric because recurring revenue is more predictable and valuable than one-time revenue.
• GMV multiples: For marketplaces, gross merchandise value multiplied by a take rate can approximate revenue, and the resulting revenue is then valued on a multiple.
• User-based metrics: For consumer companies with large user bases but limited monetization, per-user valuations (price per monthly active user) can be useful. Instagram was famously valued at roughly $30 per user when Facebook acquired it for $1 billion.

Data sources for comps include PitchBook, Crunchbase, publicly available funding announcements, SEC filings for later-stage companies, and intelligence from investors and advisors who see a high volume of deals. The challenge is that private company data is often incomplete or outdated, and headline valuations don't always reflect the full economic terms of the deal.

Discounted Cash Flow (DCF) Analysis

Discounted cash flow analysis is the gold standard of valuation in traditional finance, but it's used sparingly for early-stage startups. The reason is simple: DCF requires projecting future cash flows with reasonable accuracy, and early-stage companies have neither the historical data nor the predictability to make those projections reliable.

That said, DCF becomes increasingly relevant as companies mature. By Series B or C, a company has enough operating history to project revenue, costs, and cash flows with reasonable confidence. The DCF approach values the company as the present value of all future cash flows, discounted at a rate that reflects the risk of those cash flows materializing.

The discount rate for startups is significantly higher than for established companies. While a Fortune 500 company might use a discount rate of 8% to 12%, a Series A startup might warrant a discount rate of 30% to 60% or more, reflecting the uncertainty of its future cash flows. This high discount rate dramatically reduces the present value, which is why DCF often produces lower valuations than other methods for high-growth startups.

The terminal value — what the company is worth at the end of your explicit forecast period — typically accounts for 70% to 90% of the total DCF value for growth companies. This means the assumptions you make about long-term growth rates and margins have an outsized impact on the final number. Small changes in terminal value assumptions can swing the valuation by 50% or more.

The Scorecard Method

Developed by angel investor Bill Payne, the scorecard method is designed specifically for pre-revenue startups where financial methods offer limited utility. It starts with the average pre-money valuation for similar companies in the same region and stage, then adjusts up or down based on qualitative factors.

The scorecard typically evaluates six factors, each with a weight:

• Strength of the team (0–30% weight): The most heavily weighted factor for early-stage companies. Experienced founders with relevant domain expertise and a track record of execution command premium valuations.
• Size of the opportunity (0–25% weight): How large is the addressable market? Is this a $100 million opportunity or a $10 billion opportunity?
• Product/technology (0–15% weight): How differentiated is the product? Is there a technical moat? Is the product built or still conceptual?
• Competitive environment (0–10% weight): How crowded is the market? Are there well-funded incumbents?
• Marketing/sales channels (0–10% weight): Does the company have a clear go-to-market strategy and early evidence of customer acquisition?
• Need for additional investment (0–10% weight): How capital-efficient is the business? Will it need many rounds of additional funding?

Each factor is scored relative to the "average" company in the cohort, and the weighted sum produces an adjustment factor. If the average pre-seed valuation in your market is $5 million pre-money and your scorecard produces a 1.3x adjustment, your indicated valuation is $6.5 million. The method is inherently subjective, but it provides a structured framework for the qualitative judgment that dominates early-stage investing.

The Berkus Method

Created by angel investor Dave Berkus, this method assigns a dollar value to five key risk-reduction milestones. It's particularly useful for very early-stage companies — pre-revenue or even pre-product — where other methods simply don't apply.

The five elements, each worth up to $500,000 in Berkus's original framework (though the numbers have been updated for current market conditions):

• Sound idea (basic value): The concept itself addresses a real market need. Worth up to $500K.
• Prototype (technology risk reduction): A working prototype reduces the risk that the product can't be built. Worth up to $500K.
• Quality management team (execution risk reduction): A proven team reduces the risk of poor execution. Worth up to $500K.
• Strategic relationships (market risk reduction): Partnerships, advisors, or early customer relationships reduce go-to-market risk. Worth up to $500K.
• Product rollout or sales (production risk reduction): Actual revenue or deployed product reduces the risk that customers won't pay. Worth up to $500K.

In practice, these values have inflated significantly. In hot markets like San Francisco or New York in 2026, each element might be worth $500K to $2M, producing maximum pre-money valuations of $2.5M to $10M. The Berkus method is best used as a sanity check or starting point rather than a definitive valuation tool.

Cost-to-Duplicate Method

The cost-to-duplicate method values a startup based on what it would cost to build an identical company from scratch. This includes all tangible assets: product development costs, technology infrastructure, intellectual property, inventory, and any physical assets. The idea is that a rational buyer would not pay more for a company than it would cost to recreate it.

This method provides a useful floor valuation but almost always undervalues a startup. The reason is that it only captures the tangible, backward-looking costs and ignores the intangible value: the team's expertise and relationships, the customer base, brand recognition, market position, and future growth potential. A company might have spent $2 million building its product, but if that product now generates $1 million in monthly recurring revenue, it's clearly worth far more than $2 million.

The cost-to-duplicate method is most useful in two scenarios: as a minimum valuation benchmark, and for companies whose primary value lies in proprietary technology or intellectual property rather than market traction. Deep tech companies with years of R&D and multiple patents might find this method produces a more reasonable starting point than revenue-based methods.

How Market Conditions Affect Valuation

Startup valuations don't exist in a vacuum. They're heavily influenced by macroeconomic conditions, public market performance, LP allocations to venture, and overall market sentiment. The same company with the same metrics might be valued at $30 million pre-money in a hot market and $15 million in a correction.

The 2020-2021 period saw some of the highest venture valuations in history, driven by low interest rates, massive LP inflows, and tech-sector exuberance. Median pre-money valuations for Series A rounds exceeded $40 million in some markets. The correction that followed in 2022-2023 saw those same metrics drop by 30% to 50%. By 2025-2026, valuations have stabilized at a new baseline that reflects tighter monetary policy and more disciplined investor behavior.

Interest rates have a particularly strong effect on growth company valuations. Higher rates increase discount rates, which reduces the present value of future cash flows. They also make fixed-income investments more attractive relative to risky venture bets, reducing capital flows into the asset class. Founders should pay attention to the macro environment when planning their fundraise timing.

Sector preferences also shift. In 2026, AI and defense tech command premium valuations, while consumer social and crypto face more skepticism. These sector cycles can add 50% or more to the valuation of a company in a favored category, even holding all other factors constant.

Practical Tips for Founders Navigating Valuation

Understanding valuation theory is important, but here's the practical advice that matters most when you're actually in a fundraise.

Don't optimize solely for valuation. A higher valuation with bad terms — participating liquidation preferences, full ratchet anti-dilution, excessive board control — can be far worse than a lower valuation with clean terms. The headline number is just one dimension of the deal.

Create competitive dynamics. Nothing drives valuation higher than having multiple term sheets. If three investors want to lead your round, market forces will push the price up naturally. This is why timing your process to create simultaneous interest is so important.

Know your walk-away number. Before you start raising, decide the minimum valuation you'd accept. This prevents you from getting anchored by a lowball offer and making concessions you'll regret. Your walk-away number should be informed by your burn rate, runway needs, and the dilution you're willing to accept.

Consider the next round. A valuation that's too high today can create a "down round" risk if you can't grow into it fast enough. A down round — raising at a lower valuation than your previous round — is demoralizing for the team, triggers anti-dilution provisions that hurt founders, and signals weakness to the market. It's often better to raise at a slightly lower but achievable valuation and then blow past it.

Use multiple methods as triangulation. Run the VC method, pull comps, and if applicable, build a DCF. If all three methods converge around the same range, you have a defensible valuation. If they diverge significantly, investigate why and use the analysis to identify which assumptions are driving the discrepancy.

Ultimately, your startup is worth exactly what someone is willing to pay for a piece of it. All the models and methods in this guide are tools for informed negotiation, not definitive answers. The founder who combines analytical rigor with negotiation skill and market awareness will consistently achieve better outcomes than one who relies on any single approach.